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Abstract
Objective: The protective effect of aprotinin, which is a protease inhibitor, was assessed in a rabbit spinal cord ischemia model.
Design: Randomized, controlled, prospective study. Setting: University research laboratory. Subjects: New Zealand white rabbits
(36) of both sexes. Methods: In 24 animals, ischemia was induced with midline laparotomy and clamping the aorta just distal to
left renal artery and proximal to aortic bifurcation for 20 min. Aprotinin was given 30 000 KIU as a short intravenous injection
after anesthesia, and was followed by 10 000 KIU/h by continuous infusion in group 1 (n=12). Similar volume of saline solution
was used in control group of animals (group 2, n=12). Group 3 of animals (sham group, n=12) were anesthetized and subjected
to laparotomy without aortic occlusion. Physiological parameters and somatosensory evoked-potentials (SEP) were monitored in
animals before ischemia, during ischemia and in the first 60 min of reperfusion. Their neurological outcome was clinically
evaluated up to 48 h postischemia. Their motor function was scored, and the intergroup differences were compared. The animals
were sacrificed after two days of postischemia. Their spinal cord, abdominal aorta, and its branches were processed for
histopathological examination. Results: In group 3, SEP amplitudes did not change during the procedures, and all animals
recovered without neurologic deficits. At the end of ischemic period, the average amplitude was reduced to 5397% of the baseline
in all ischemic animals. This was followed by a gradual return to 8998 and 81913% of the initial amplitude after 60 min of
reperfusion in group 1 and group 2 correspondingly (P\0.05). The average motor function score was significantly higher in
group 1 than group 2 at 24 and 48 h after the ischemic insult (PB0.05). Histological observations were clearly correlated with
the neurological findings. Conclusion: The results suggest that aprotinin reduces spinal cord injury and preserves neurologic
function in transient spinal cord ischemia in rabbits. © 1997 Elsevier Science B.V.
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1. Introduction
Ischemic spinal cord injury represents the main com-
plication in surgical repair of thoracic and thoracoab-
dominal aneurisms and remains a persistent clinical
problem. Temporary aortic occlusion may produce a
critical reduction in spinal cord perfusion with a risk of
irreversible ischemic injury. Reperfusion may also cause
numerous further negative effect in the case of ischemia
is severe and prolonged.
To date, numerous clinical and laboratory studies in
attempt to decrease the risk of this devastating compli-
cation have been reported. Some of these techniques
have met with varying success and presently used in
several clinical settings, such as regional or systemic
hypothermia [1], cerebrospinal fluid drainage [2], shunts
[3], monitoring of somatosensory evoked potentials and
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B.H. Şirin et al. / European Journal of Cardio-thoracic Surgery 12 (1997) 913–918914
reimplantation of major intercostal or lumbar arteries
[4]. Numerous adjunctive medications have also been
used for preserving spinal cord function [5,6]. Despite
their use, paraplegia remains a persistent complication
of the operations on descending aorta. The reported
prevalence of neurologic injury for these operations
ranges up to %40 [7].
In the mechanisms of the pathogenesis of ischemia-
reperfusion injury, activated neutrophils are thought to
be important in terms of their ability to produce vari-
ous kinds of proteinases, which can degrade various
proteins constructing human tissues [8]. Similarly, acti-
vation of blood protease cascades may contribute to
cellular injury under this condition [9,10].
Aprotinin is a serine-protease inhibitor and has been
shown to inhibit activation of kallikrein-kinin system,
plasmin fibrinolysis system, preserve platelet function
and partially inhibit neutrophil activation [11,12].
Since the discovery of aprotinin in 1930, its clinical
application has been sought for a number of situations,
including cardiopulmonary bypass and ischemia-reper-
fusion, in which activation of blood protease cascades
may play an important role [12,13]. The protective
effect of aprotinin on ischemia-reperfusion injury has
been proven on various tissues such as brain and
myocardium [9,10,13,14]. However, no study attempt-
ing to describe the protective effect of this agent on
spinal cord ischemia appeared. In this study, we exam-
ined the effects of aprotinin on histopathological
changes and neurologic recovery in temporary induced
spinal cord ischemia in rabbits.
2. Material and methods
2.1. Animal preparation
After approval of the study by the local Institutional
Committee, experiments were performed on 36 New
Zealand white rabbits of both sexes, each weighing
2.4–3.3 kg (mean 2.9 kg). Rabbits were anesthetized
with intramuscular ketamine with an initial dose of 50
mg/kg, followed by 25 mg/kg fractionally as needed
during the procedure. No animals received haemody-
namic or ventilatory support. The animals were placed
in a nose cone to breath oxygen at a rate of 3 l/min.
Body temperature monitored with a thermistor probe
in rectum and maintained close to 38°C using heating
pads. An intravenous catheter (24 gauge) was placed in
an ear vein, and preoperatively cefazolin 10 mg/kg was
given as a single dose. Maintenance fluid of 0.9% NaCl
was infused at a rate of 20 ml/h during the procedure.
A femoral artery was exposed for arterial line with a
catheter (24 gauge) and this catheter was connected to
a blood pressure/heart rate transducer and monitor
(Hewlett-Packard 1495C). Determinations of blood glu-
cose, hemoglobin level, blood gases-electrolytes and pH
were also accomplished with this line (Stat Profile 5
autoanalyser).
2.2. Experimental groups and surgical procedure
Rabbits were randomly allocated into three groups
each consisting of 12 rabbits. In group 1, aprotinin
(10 000 KIU/ml) was injected 30 000 KIU/kg as an
initial bolus via the ear vein immediately after anesthe-
sia and perfusion was continued at a rate of 10 000
KIU/h. A similar volume of saline solution was given in
the control groups correspondingly. After the surgical
preparation, using aseptic techniques, a midline laparo-
tomy was performed. The abdominal aorta was ex-
posed and mobilized from just inferior to the left renal
vein down to aortic bifurcation. Each rabbit was anti-
coagulated with heparine 150 U/kg. In group 1 and
group-2, spinal cord ischemia was induced with clamp-
ing the aorta just below the left renal vein with a
bulldog clamp (FB328). A second similar clamp was
placed above the aortic bifurcation for occluding iliac
collateral circulation. Animals were subjected to 20 min
of crossclamp time. After the ischemic period, the
clamps were removed and restoration of the blood flow
was verified visually. The abdomen was then closed. In
group 3 of animals (sham operated), laparotomy inci-
sion was left open for 20 min corresponding to spinal
ischemia period but the aorta was not occluded. This
group of animals were used for eliciting the effects of
anesthesia and operation on results.
Blood samples were obtained before ischemia in
basal condition, at 5th and 60th minute of reperfusion.
The systemic acidosis determined by measurement of
arterial blood gases was corrected by intravenous ad-
ministration of sodium bicarbonate.
2.3. SEP recording
To asses the acute neurologic recovery, somatosen-
sory evoked potentials (SEP) were recorded before is-
chemia, during ischemia and first 60 min of reperfusion
with 5 min intervals. SEP responses were evaluated for
recovery to the percentages of their baseline control
values. Nihon Kohden Neuropack II plus (MEB 5000)
was used for the recordings. A teflon-coated silver wire
active electrode was inserted over the parietal region 2
mm lateral to midline and 2 mm caudal from the
coronal suture. A similar reference electrode was in-
serted to midline over nasion. The sciatic nerve con-
tralaterale to the scull electrode was stimulated by
surface electrodes. The stimulus rate was 5/s with a
duration of 0.2 ms and the stimulus intensity was 3–4
mA. 256 responses were averaged. Bandpass filter was
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2.4. Postoperati6e care and assessment
Arterial and venous lines were removed and all med-
ications were stopped at the 60th min of reperfusion.
When the animals awakened from anesthesia, they were
returned to their cages. The Crade maneuver was used
to empty the bladders of the paraplegic animals at least
twice daily. Six animals (three rabbits originally as-
signed to the group 1, 2 to group 2, and 1 to group 3)
died in the early postoperative period (within first 8 h)
and they were excluded from the study. Others survived
without any clinical sign of pathology except paraple-
gia.
The animals were examined neurologically 24 and 48
h after the operation and spinal cord function was
assessed by an independent observer. Bladder function
was evaluated, and the motor function of hindlimbs
was scored by the following scale:
0, no movement;
1, trace movement;
2, able to sit but only with assistance;
3, able to sit without assistance but cannot hop;
4, able to hop but without normal strength;
5, normal motor function.
2.5. Histopathology
After the last neurological examination at 48 h post-
operation, the animals were anaesthetized with intra-
muscular ketamine 50 mg/kg in dose and killed with
transcardially perfused 10% neutral formol. The
retroperitoneal region including abdominal aorta and
it’s branches were removed extensively and fixed in 10%
formol solution. The spinal cord was than removed,
immersed in the same fixative, and postfixed for about
14 days before being set in paraffin blocks for section-
ing. Sections of the thoracic and lumbar cord were
stained with hemotoxylin and eosin. Abdominal aorta
and its branches were examined for revealing possible
thrombosis or embolic occlusion.
2.6. Statistical analysis
All data are expressed as means9S.D. Control vari-
ables such as blood pressures, blood gases, and pH
were compared among groups with one-way analysis of
variance. Nonparametric analyses with Wilcoxon–
Mann–Whitney U-test using the Bonferroni correction
were performed on the data of the hindlimb motor
scores. Somatosensory evoked potential data are ex-
pressed as percent of control. Recovery of SEP ampli-
tude in aprotinin treated animals was compared with
that value of ischemia control animals using t-tests and
Bonferroni corrections. Fisher exact probability test
was used in the analysis of bladder function. A P value
less than 0.05 was considered significant.
3. Results
3.1. Physiological parameters
No differences in mean levels of blood glucose, in
arterial blood gases, in pH, in arterial pressures or body
temperatures were noted among the control groups and
the group treated with aprotinin before ischemia. These
physiological parameters stayed quite similar during the
procedure in group 3 of animals. The femoral artery
blood pressure fell and remained near zero in the
animals subjected to ischemia during the ischemic pe-
riod and became gradually normal within the first few
min of reperfusion. In these groups of animals, a slight
decrease in arterial pH observed at the 3rd min of
reperfusion were corrected with sodium bicarbonate
injection. There was no difference in any of the three
groups in the amount of bicarbonate required to cor-
rect the acidosis (0.691.3 mEq in group 1; 0.891.6
mEq in group 2; and 0.090.0 mEq in group 3).
3.2. SEP recordings
SEP recordings consistently showed a large negative
peak (N1) with an average latency of 1192 ms, and a
positive peak (P1) with an average latency of 1993 ms
and two other negative following peaks. The peaks
were stable in group 3 control animals during the
procedure. In ischemic groups, N1 and P1 peaks pro-
gressively declining with an average of 1193 min after
aortic occusion while other waves were resistant to
ischemia. At the end of ischemic period N1-P1 ampli-
tude decreased 42–68% of preischemic baseline level in
all ischemic animals. The average amplitude was re-
duced to 5497% and 5198% of the baseline in group
1 and group 2 correspondingly (P\0.05). This was
followed by a gradual return to 8998% of the initial
amplitude after 60 min of reperfusion in group 1. This
recovery was 81913% in group 2 of animals (P\
0.05). The typical changes in N1–P1 amplitudes are
represented in Fig. 1.
3.3. Neurological status
Group 3 control animals exhibited full neurologic
recovery after the procedure. The evaluations of the
motor function score after 24 and 48 h postischemia in
group 1 and group 2 are shown in table. Most of
animals (95%) exhibited score-4 or score-3 motor func-
tion at 24 h and full neurologic recovery was not seen
in any of these animals. Additional deterioration in
neurologic score was observed in 2 rabbits in group 1 (1
rabbit from 4 to 3 and 1 rabbit from 4 to 2) and in 3
rabbits in group 2 (1 rabbit from 4 to 3, 1 rabbit from
3 to 2, and 1 rabbit from 3 to 1) within 24 to 48 h. The
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Fig. 1. The typical changes in SEP recordings. The traces of before
ischemia, at the end of ischemia and 60th min of reperfusion.
() Preischemia; () at the end of ischemia; () at 60th min of
reperfusion.
Fig. 2. Normal morphological appearance of unaltered structure of
spinal cord and central gray matter (Group 1, score-4 of motor
neurological function, lumbosacral segment, ×40 hemotoxylin and
eosin).
predominant localization in lumbosacral segments
(Figs. 3 and 4).
4. Discussion
Aprotinin inhibits a wide range of serine protease
with varying efficacy. It has been shown in vitro that it
directly inhibits trypsin, plasmin, and kallikrein of hu-
man origin and weakly inhibits the neutral lysosomal
elastase and cathepsin G from human neutrophils [13].
It has been also shown that aprotinin reduces activation
of neutrophils possibly by kallikrein inhibition during
cardiopulmonary bypass [15] and inflammation [16].
There is evidence from models of cerebral ischemia
that aprotinin has some beneficial effects on recovery.
Kamiya demonstrated that ischemic brain edema is
closely related to plasma and brain tissue bradikinin
levels and pretreatment with aprotinin reduces cerebral
water content after ischemia in a rat model [9].
Bradykinin is generated by activation of kallikrein–
kinin system and is known to be an important chemical
than group 2 at both after 24 and 48 h postischemia
(PB0.05) Table 1.
Bladder function was retained to 48 h postischemia
in 7 of 9 animals treated with aprotinin (group 1)
compared with 6 of 10 group 2 control animals (P\
0.05)
3.4. Histopathological findings
Histologic examination of abdominal aorta and its
branches were normal and reveal no thrombus forma-
tion in all animals.
The histopathological findings of spinal cord were
correlating with the neurological status. The animals
with high motor score exhibited unaltered structure of
gray matter or minimal necrosis in small patchy areas
(Fig. 2). In contrast, animals with low motor score had
typical infarctions of variable size in central gray matter
which were detected primarily in the medial zone, with
Table 1
Scores of hindlimb motor functions examined in the groups 24 and 48 h after the operation
Average motor scoreMotor scorenAnimal groups
0 1 2 3 4 5
Group 1
— — — 224th h 79 — 3.7890.44*
3.4490.72*—59 348th h 1——
Group 2
—— 3.1090.56—10 224th h 71
48th h 2.6090.84—1531—10
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Fig. 3. Neuronal death characterized by blured sytoplasmic border,
degranulation of nissl substances and karyolysis (Group 2, score-3 of
motor neurological function, lumbosacral segment, 400 hemotoxylin
and eosin).
abdominal aorta for occluding the iliac collateral circu-
lation and we monitored the spinal cord ischemia with
SEP. Monitoring of SEP during aortic occlusion has
been used for identification and exclusion of animals
that had sufficient collateral blood flow to permit the
spinal cord to survive long periods of aortic occlusion
[5]. In the present study, despite of minimal individual
variations, SEP amplitudes decreased to about 50% of
their preischemic values in most animals at 20th min of
ischemia. Previous studies have shown that a decrease
of 15–20% in amplitude can be taken as a criteria of
significant SEP changes [18]. In the present study, mon-
itoring of SEP in this model has permitted observation
of similar collateral blood flow properties in studied
groups of animals.
While some authors attempt to define the SEP recov-
ery during early reperfusion as a predictor of neurolog-
ical outcome [5], some articles have documented some
examples where SEP did not accurately predict postop-
erative deficits, particularly motor deficits [19,20]. In the
present study, although the difference in recovery of
SEP amplitudes did not attain statistical significance
(P\0.05), we observed significantly better neurologic
outcomes (PB0.05) in aprotinin treated group.
Spinal cord monitoring can be based on noninvasive
recording of cortical SEP to lower limb stimulation, or
to more invasive recordings involving electrodes in
spinal bony spinous processes, intervertebral ligaments
or spinal epidural space. Cortical SEP recently have
been criticized because of occasional false correlations
with neurological outcome. However, most authors still
believe that the cortical SEP reliably reflect the spinal
cord function [21]. Thus, we preferred cortical SEP
monitoring because of it is safe, easy and it does not
prolong the operative procedure. The possible effects of
used anesthesia and operation on SEP recordings was
ruled out with the evaluation of group 3 in the present
study.
It is known that deterioration in neurological func-
tion after transient spinal cord ischemia of rabbits
usually worsens 24–48 h after injury [22,23]. In this
study, 2 rabbits in group 1 and 3 rabbits in group 2
showed additional motor deterioration within 24–48 h
after the ischemic insult (26%). Although the mecha-
nisms to account for this progressive deterioration re-
main uncertain, some investigators have suggested that
cytotoxic substances such as free radicals, excitotoxins,
proteases, or arachidonic acid metabolites found in
damaged neural tissue are responsible [22,23].
Aprotinin is a potentially antigenic agent and may
cause allergic reactions [24]. Its effects on postoperative
thrombosis formation have also been discussed exten-
sively [13,25]. We have no observation suggesting these
adverse effects of aprotinin in the rabbits in the present
study. Histopathological examination of abdominal
aorta and its branches revealed no thrombus formation
in both aprotinin treated and control groups.
mediator of local inflammation. It also effects blood
vessels and vascular smooth muscle and increase va-
sodilatation and vascular permeability resulting with
tissue odema [9,15]. Aoki demonstrated that aprotinin
enhances acute recovery of cerebral energy
methabolism after hypothermic circulatory arrest in
piglets through mechanisms involving preservation of
vascular integrity [10]. The present study extends these
observations to the spinal cord.
The rabbit spinal cord is a reliable model for system-
atically and rapidly observing the protective effects of
investigated agents on ischemia and reperfusion injury.
However, the rabbit abdominal aorta ligation does not
produce complete ischemia in the spinal cord. There are
considerable individual variations in the residual collat-
eral blood flow, and in most animals, about 2% of
normal blood flow remains after 20 min of ligation [17].
In the present study, we used a second clamp to distal
Fig. 4. Large necrosis in central gray matter and capiller proliferation
(Group 2, score-2 of motor neurological function, lumbosacral seg-
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In conclusion, the results suggest that aprotinin re-
duces ischemic and reperfusion damage in transient
spinal cord ischemia and provide better neurologic
outcome. Aprotinin does not cross the blood-brain
barrier; therefore its main site of action must be in the
microcirculation. We believe that it decreases ischemic
injury in endothelium by reducing bradikinin genera-
tion and provides better microcirculatory environment
during early reperfusion by preventing endothelial cell
lysis by proteases from activated neutrophils. There are
considerable species differences in specific protease
affinity to aprotinin, so that the results of an animal
study such as this may not be fully reproducible in
humans. Further studies are needed to define biochemi-
cal aspects of these events and to determine the correct
dose necessary for maximal benefit.
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